Status:

COMPLETED

A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator

Lead Sponsor:

InteKrin Therapeutics, Inc.

Conditions:

Type 2 Diabetes Mellitus

Eligibility:

All Genders

30-75 years

Phase:

PHASE2

Brief Summary

This is a 24 week study comparing the efficacy of four dose levels of INT131 besylate with pioglitazone HCl in patients with type 2 diabetes. Eligible patients will be men and women (of non-childbeari...

Eligibility Criteria

Inclusion

  • Diagnosis of Type 2 diabetes and on either sulfonylurea monotherapy or sulfonylurea plus metformin combination therapy for at least 3 months at stable dose
  • Males and Females (of non-childbearing potential or who are using dual barrier methods of contraception) between 30 and 75 years of age
  • HbA1c must be ≥7.5% and ≤10% at screening
  • Fasting Plasma Glucose must be \<240 mg/dL at screening

Exclusion

  • History of type 1 diabetes
  • History of diabetic ketoacidosis
  • NYHA Class III or IV cardiac status or hospitalization for congestive heart failure within 6 weeks prior to Visit 1
  • Treatment with any non-peroxisome proliferator-activated receptor (non-PPAR) antidiabetic agent, investigational or approved, other than metformin or permitted sulfonylureas within 3 months prior to screening
  • Treatment with rosiglitazone, pioglitazone, or any PPAR investigational antidiabetic agent within 6 month prior to screening
  • Body mass index \>45 kg/m2
  • Fasting triglycerides \>500 mg/dL
  • Uncontrolled hypertension (sitting systolic blood pressure \>160 mmHg and/or sitting diastolic blood pressure \>100 mmHg
  • Presence of diabetic complications, which in the opinion of the investigator, would complicate the subject's participation in the study (i.e., require initiation of new medication)

Key Trial Info

Start Date :

February 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2009

Estimated Enrollment :

367 Patients enrolled

Trial Details

Trial ID

NCT00631007

Start Date

February 1 2008

End Date

September 1 2009

Last Update

September 13 2010

Active Locations (66)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 17 (66 locations)

1

Northern California Research

Carmichael, California, United States, 95608

2

National Research Institute

Los Angeles, California, United States, 90057

3

VA San Diego Healthcare System

San Diego, California, United States, 92161

4

Apex Research Institute

Santa Ana, California, United States, 92705